Clinical Trial: Neuromodulation for a Novel OCD Biomarker and Treatment
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: OCD
Study Type: INTERVENTIONAL
Official Title: Neuromodulation for a Novel OCD Biomarker and Treatment
Brief Summary:
Although multiple treatments for OCD exist, slow symptom decrease, high remission, and significant side effects for some OCD patients limit their efficacy.More research into the precise neural mechanisms and linked cognitive functions in OCD is also necessary.To address both concerns, this study by Dr. Reinhart and his team will test a new, non-invasive, and well-tolerated neuromodulation method for reducing OCD symptoms, based on reward-related rhythms of the orbitofrontal cortex (OFC; a brain region responsible…
Read more